Literature DB >> 26367520

The Promotion of Medical Products in the 21st Century: Off-label Marketing and First Amendment Concerns.

Joshua M Sharfstein1, Alta Charo2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26367520     DOI: 10.1001/jama.2015.12045

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Tim K Mackey
Journal:  Int J Health Policy Manag       Date:  2016-02-03

2.  An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

Authors:  Spencer Phillips Hey; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2016-03-15       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.